ENTITY
Telix Pharmaceuticals

Telix Pharmaceuticals (TLX AU)

151
Analysis
Health Care • Australia
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
more
bearish•Quantitative Analysis
•04 Sep 2025 17:03

ASX Short Interest Weekly (Aug 29th): Reece, Flight Centre, Sigma Pharmaceuticals, Goodman

We analyzed ASX short interest report for the past week and highlight short interest changes in Reece, Flight Centre, Sigma Pharmaceuticals,...

Logo
463 Views
Share
bullish•Quantitative Analysis
•28 Aug 2025 15:55

ASX Short Interest Weekly (Aug 22nd): Bluescope Steel, CSL, Wesfarmers, Northern Star Resources

We analyzed ASX short interest report for the past week and highlight short interest changes in Bluescope Steel, CSL, Wesfarmers, Northern Star...

Logo
424 Views
Share
bullish•Telix Pharmaceuticals
•23 Aug 2025 08:30

Telix Pharmaceuticals (TLX AU): Here’s Why Sentiment Has Improved

​Telix Pharmaceuticals reports strong revenue growth in 1H25, driven by Illuccix. Illuccix global sales were up 29% YoY, reflecting continued...

Logo
564 Views
Share
bearish•Atlas Arteria
•20 Aug 2025 05:30

MV Australia Equal Weight Index Rebalance Preview: Three Potential Deletions in September

We do not forecast any inclusions but there could be 3 deletions. Just capping changes will lead to one-way turnover of 3.8% and a round-trip trade...

Logo
703 Views
Share
bearish•Quantitative Analysis
•15 Aug 2025 11:40

ASX Short Interest Weekly (Aug 8th): Wesfarmers, Infratil, Iluka Resources, Bigtincan, Auswide Bank

We analyzed ASX short interest report for the past week and highlight short interest changes in Wesfarmers, Infratil, Iluka Resources, Bigtincan,...

Logo
601 Views
Share
x